Analysis of statistical indicators of the population of Saint Petersburg with malignant neoplasms of pancreas
- 作者: Moiseenko V.1, Pavlovsky A.1, Granov D.1, Kochorova L.2, Dodonova I.2, Khizha V.3, Yazenok A.3, Yakovenko T.4
-
隶属关系:
- Russian Scientific Center of Radiology and Surgical Technologies named after Academician A.M. Granov
- First St. Petersburg Medical University named after Academician I.P. Pavlov
- Medical Information and Analytical Center
- North-West State Medical University named after I.I. Mechnikov
- 期: 卷 23, 编号 2 (2021)
- 页面: 155-164
- 栏目: Public Health
- URL: https://journals.rcsi.science/1682-7392/article/view/60343
- DOI: https://doi.org/10.17816/brmma60343
- ID: 60343
如何引用文章
详细
Morbidity and mortality from pancreatic cancer is an urgent medical and social problem. Evaluation of statistical indicators in dynamics makes it possible to identify organizational and clinical problems in providing care to patients with malignant neoplasms of the pancreas. Medical and statistical indicators of incidence of malignant pancreatic neoplasms in St. Petersburg residents are evaluated. The assessment of medical and statistical indicators of the incidence of malignant neoplasms of the pancreas in residents of St. Petersburg. Statistical data were studied for the period from 2014 to 2019. The increase in the "rough" indicator of primary morbidity changed from 417.99 per 100 thousand population in 2014 to 505.6 in 2019. In the structure of primary cancer incidence, the indicator of active detection of pancreatic cancer glands in 2014 amounted to 3.6%, in 2019 — 3.8%. The proportion of patients with diagnoses confirmed morphologically increased from 48.9% to 61.4%. The proportion of patients with newly diagnosed stage IV of the disease changed from 39.5% in 2014 to 51.4% in 2019, and in patients with stage III in 2019 it was 33.3% (a decrease in comparison with 2014 — 15.3%). In 2019, the disease was diagnosed at stage II in 15.2% of patients. The proportion of patients with stage I in 2019 was 6.6%, this indicator in 2014 was registered at the level of 19.2%. From 2014 to 2019, the one-year mortality rate did not change and amounted to 67.9 and 67.4%, respectively (the decrease was 0.7%). Over the past 5 years, there has been no significant downward trend in the "rough" incidence and mortality rates from pancreatic cancer. However, in the dynamics, there was an increase in the number of patients registered for 5 or more years, and an increase in the accumulation index of the contingent of patients with pancreatic cancer.
作者简介
Vladislav Moiseenko
Russian Scientific Center of Radiology and Surgical Technologies named after Academician A.M. Granov
编辑信件的主要联系方式.
Email: tmpr@inbox.ru
ORCID iD: 0000-0002-5058-8821
candidate of medical sciences
俄罗斯联邦, Saint PetersburgAlexander Pavlovsky
Russian Scientific Center of Radiology and Surgical Technologies named after Academician A.M. Granov
Email: tmpr@inbox.ru
ORCID iD: 0000-0003-3994-1329
doctor of medical sciences
俄罗斯联邦, Saint PetersburgDmitry Granov
Russian Scientific Center of Radiology and Surgical Technologies named after Academician A.M. Granov
Email: d.granov@gmail.ru
ORCID iD: 0000-0002-8746-8452
doctor of medical sciences, professor
俄罗斯联邦, Saint PetersburgLarisa Kochorova
First St. Petersburg Medical University named after Academician I.P. Pavlov
Email: larisakocherova@1spbgmu.ru
ORCID iD: 0000-0002-9016-8602
SPIN 代码: 5332-1103
doctor of medical sciences, professor
俄罗斯联邦, Saint PetersburgInna Dodonova
First St. Petersburg Medical University named after Academician I.P. Pavlov
Email: dodonova@1spbgmu.ru
ORCID iD: 0000-0001-9258-4389
SPIN 代码: 7483-5108
assistant
俄罗斯联邦, Saint PetersburgValentin Khizha
Medical Information and Analytical Center
Email: apink1@mail.ru
candidate of medical sciences
俄罗斯联邦, Saint PetersburgArkadii Yazenok
Medical Information and Analytical Center
Email: AYazenok@yandex.ru
doctor of medical sciences, associate professor
俄罗斯联邦, Saint PetersburgTaras Yakovenko
North-West State Medical University named after I.I. Mechnikov
Email: jakovenko.t@szgmu.ru
candidate of medical sciences
俄罗斯联邦, Saint Petersburg参考
- Vincent A, Herman J, Schulick R, et al. Lancet. 2011;378(9791):607–620. doi: 10.1016/S0140-6736(10)62307-0
- Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;44:9694-9705. doi: 10.3748/wjg.v22.i44.9694
- Kaprin AD, Starinskij VV, Petrova GV. Zlokachestvennye novoobrazovanija v Rossii v 2018 godu (zabolevaemost’ i smertnost’). Moscow: MNIOI im. P.A. Gercena — filial FGBU "NMIC radiologii" Minzdrava Rossii; 2019. (In Russ.).
- Prashanth R, Tagore S, Vinaya G. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27. doi: 10.14740/wjon1166
- Ignat’eva VI, Avksent`eva MV. Analiz metodologicheskih osobennostej issledovanij po izucheniju social’no-jekonomicheskogo bremeni zabolevanij v Rossii v ramkah razrabotki standartnoj metodiki analiza stoimosti bolezni s cel’ju ee ispol’zovanija v ocenke tehnologij zdravoohranenija. Farmakojekonomika. Sovremennaja farmakojekonomika i farmakojepidemiologija. 2014;7(3):3–11. (In Russ.).